Medpace Holdings, Inc. Sustainability Profile
Medpace Holdings, Inc., a leading global clinical research organisation, is headquartered in the United States and operates extensively across North America, Europe, and Asia. Founded in 1992, Medpace has established itself as a trusted partner in the pharmaceutical and biotechnology industries, specialising in full-service clinical development and regulatory consulting. The company offers a comprehensive range of services, including clinical trial management, data management, and biostatistics, which are tailored to meet the unique needs of its clients. Medpace's commitment to quality and efficiency has positioned it as a preferred choice for sponsors seeking to navigate the complexities of clinical trials. With a strong track record of successful project delivery and a focus on therapeutic expertise, Medpace Holdings, Inc. continues to achieve significant milestones, solidifying its reputation as a key player in the clinical research landscape.
DitchCarbon Score
How does Medpace Holdings, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Medpace Holdings, Inc.'s score of 25 is lower than 61% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Medpace Holdings, Inc.'s reported carbon emissions
Medpace Holdings, Inc., headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. As a result, Medpace's climate commitments and initiatives remain unclear, and there is no inherited emissions data from a parent or related organization. The company has not established any Science-Based Targets Initiative (SBTi) reduction targets or other significant climate initiatives at this time. In the context of the industry, it is essential for organisations like Medpace to develop and communicate clear climate strategies to align with global sustainability goals and enhance their environmental accountability.
How Carbon Intensive is Medpace Holdings, Inc.'s Industry?
How Carbon Intensive is Medpace Holdings, Inc.'s Location?
Medpace Holdings, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Medpace Holdings, Inc. has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
